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Overshoot during phenotypic 
switching of cancer cell 
populations
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Andrea Piccinini5, Christopher R. Myers6,7, James P. Sethna6, Costanza Giampietro8, 
Stefano Zapperi1,2,9,10 & Caterina A. M. La Porta8
The dynamics of tumor cell populations is hotly debated: do populations derive hierarchically from 
a subpopulation of cancer stem cells (CSCs), or are stochastic transitions that mutate differentiated 
cancer cells to CSCs important? Here we argue that regulation must also be important. We sort 
human melanoma cells using three distinct cancer stem cell (CSC) markers — CXCR6, CD271 and 
ABCG2 — and observe that the fraction of non-CSC-marked cells first overshoots to a higher level 
and then returns to the level of unsorted cells. This clearly indicates that the CSC population is 
homeostatically regulated. Combining experimental measurements with theoretical modeling and 
numerical simulations, we show that the population dynamics of cancer cells is associated with a 
complex miRNA network regulating the Wnt and PI3K pathways. Hence phenotypic switching is 
not stochastic, but is tightly regulated by the balance between positive and negative cells in the 
population. Reducing the fraction of CSCs below a threshold triggers massive phenotypic switching, 
suggesting that a therapeutic strategy based on CSC eradication is unlikely to succeed.
The cancer stem cell (CSC) hypothesis suggests that tumors are organized in an aberrant cell hierarchy, 
in which differentiated cells have a limited capacity to proliferate and are produced by a subpopulation 
of parent CSCs that replicate indefinitely1. It is challenging to identify CSCs; human biopsies taken at 
specific clinical times cannot provide a complete tumor history, and animal tumor xenografts miss the 
physiological environment in which the tumor grows2. Despite these limitations, recent experiments 
in vivo have confirmed the presence of an aggressive CSC-like subpopulation in benign and malignant 
tumors3–5.
The population dynamics of CSCs is, however, more complex than the strict hierarchy originally pro-
posed. Non-CSCs breast cancer cells can revert to a stem-cell-like state even in the absence of mutations6. 
Similarly, in melanoma a small population of CSC-like JARID1B positive cells has been shown to be 
dynamically regulated in a way that differs from the standard hierarchical CSC model7, reconciling ear-
lier findings8–10. Microenvironmental factors, such as TGFβ, are found to enhance the rate of switching 
from non-CSC cells to the CSC state11. This is in line with earlier results from our group showing that 
ABCG2 negative cells isolated from human melanoma biopsies reexpress this marker after a few gener-
ations in vitro12. The idea that the environment is able to induce cells to switch into a more aggressive 
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phenotype was confirmed by Medema and Vermeulen, who explored limiting stemness by modifying 
microenvironmental factors known to support CSCs in tumors13. While mounting experimental evi-
dence supports the switch from non-CSC cancer cells to the CSC state, the biological factors regulating 
this process are still unclear. Two possible scenarios have been invoked to solve this puzzle: the switch to 
the CSC state is either i) driven by genetic mutations or ii) regulated by epigenetic factors14.
In this paper, we report results indicating that the switching to the CSC state in human melanoma 
cells is regulated by an internal underdamped homeostatic mechanism controlling the fractional pop-
ulation, not dependent on external microenvironment. We measure the switching to the CSC state on 
the single-cell level with three biomarkers (CXCR615, ABCG212, and CD27110). Our group identified 
CXCR6 as biomarker of a CSC-like aggressive subpopulation in human melanoma cells12,15; it was also 
shown to play a critical role in stem cell biology, being linked to asymmetric cell division15. For all 
three markers, positive cells are known to give rise to a bigger tumor in immunodeficient mice than 
the negative ones10,12,15. The small tumor obtained with the negative population could be due to the use 
of an imperfect marker16, to sorting errors or to phenotypic switching6. Here we follow the population 
dynamics of the negative subpopulation for longer times than earlier studies6, recognizing that cells may 
require time to revert their phenotype (melanoma cells divide at a rate of ~0.60/day17). We observe that 
reducing the percentage of CSCs below a threshold induces cells to switch en masse, substantially over-
shooting the fraction seen in unsorted cells. This strongly suggests that a therapeutic strategy based on 
CSC eradication is unlikely to succeed.
Figure 1. Overshoot of CXCR6 and CD271 in human melanoma sorted cells. CXCR6- or CD271- 
negative cells are sorted from IgR39 cells as described in Methods and plated under standard growth 
conditions. Cells are collected 3, 10 and 20 days after sorting, and analyzed by flow cytometry. Non-specific 
mouse IgG is used as isotype control (Isotype). The distribution of the markers in unsorted cells is also 
reported (U). Flow cytometry is performed using a FACSAria flow cytometer (Becton, Dickinson and 
Company, BD, Mountain View, CA). Data are analyzed using FlowJo software (Tree Star, Inc., San Carlos, 
CA). For each flow cytometry evaluation, a minimum of 5 × 105 cells are stained and at least 50000 events 
are collected and analyzed. (a) The level of expression of each markers in unsorted cells (U) and at different 
times after sorting is reported as flow cytometric analysis of a minimum of 5 independent experiments.  
(b) Unsorted cells (U), CXCR6-positive, and CXCR6-negative cells after 10 days sorting are fixed with 3.7% 
paraformaldeide and incubated with polyclonal anti-CXCR6 antibody (1:400, Abcam, Ab8023) overnight. 
Then the cells are incubated with the secondary antibody (anti rabbit Alexa488 1:250) for 1 h and the nuclei 
counterstained with DAPI. The slides are mounted with Pro-long anti fade reagent (Invitrogen) and the 
images acquired with a Leika TCS NT confocal microscope.
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We then investigate the underlying regulatory mechanism. We provide evidence for the intriguing 
possibility that miRNAs play a key role in regulating the switch to the CSC state. miRNAs are small 
evolutionarily-conserved single-stranded RNAs which inhibit their target genes through binding to 
miRNA response elements (MREs)18. A single mRNA usually contains MREs for multiple miRNAs and, 
at the same time, an individual miRNA often targets up to 200 functionally diverse transcripts. miRNAs 
have been shown to suppress the expression of important cancer-related genes and have been proved 
useful in the diagnosis and treatment of cancer19. By studying the differential expression of miRNAs 
before and at the overshoot, we observe and characterize a complex miRNA regulatory network that 
plausibly governs the switching response.
Results
CXCR6, CD271 or ABCG2 negative human melanoma cells switch and overshoot after sorting. 
IgR39 melanoma cells that are negative for CXCR6, ABCG2 or CD271 markers are sorted by flow cytom-
etry, and then plated and grown under standard conditions. Considering that the positive cells represent 
only a very small fraction of the entire population, the possible error due to sorting is extremely low16, 
as confirmed by the FACS analyses of the negative cells immediately after sorting (Fig. S1). Cells are 
collected 3, 10 and 20 days after sorting and analyzed for each marker by flow cytometry or immuno-
fluorescence. Figure  1 shows the results for CD271 and CXCR6, while Fig. S2 reports the results for 
ABCG2. In all cases, the marker-negative cells re-express their marker in a time-dependent manner. In 
particular, the marker-positive population overshoots its initial level at 10 days post-sorting and then 
returns to the steady-state level at 20 days (Fig. 1 and Fig. S2). Immunofluorescence analysis confirms 
that CXCR6-negative cells after 10 days re-express such a factor at the same level as CXCR6-positive cells 
(Fig.  1). We next investigate whether the overshoot observed is dependent on the fraction of positive 
cells in the entire population. We thus sort by flow cytometry the CXCR6-positive cells and remix them 
with the negative ones in a fixed percentage ranging from 0.2% to 1% as shown in Fig. 2. A value around 
1% represents the physiological condition of unsorted cells (Fig.  1). After 2 and 6 days, the remixed 
cells are analyzed by flow cytometry. Figure 2 demonstrates that mixed populations with a positive CSC 
fraction at or below 0.4% massively revert their phenotype after 6 days. We have previously shown that 
CXCR6-positive cells are also ABCG2-positive15. Herein we show that there is a strong overlap between 
the CXCR6-positive and CD271-positive populations (Fig. S3). This indicates that the observed effect is 
Figure 2. The rate of phenotypic switching depends on the initial concentration of positive cells. 
(a) CXCR6-positive and -negative IgR39 cells are sorted by flow cytometry and mixed with the fraction 
of positive cells varying from 0.2 to 1%. Cells are collected 2 and 6 days after sorting and the level of 
expression of CXCR6 is quantified by flow cytometry. (b) A representative example of flow cytometry 
for different initial fractions of CXCR6 positive cells. (c) The percentage of positive cells obtained in the 
different experimental conditions.
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independent of the particular marker chosen to characterize CSCs, and in fact, the overshoot is observed 
for all markers.
Short tandem repeat analysis of CXCR6 positive and negative human melanoma cells show 
no differences. To check if CXCR6-positive and CXCR6-negative IgR39 cells display genetic differ-
ences, we analyze short tandem repeats (STR). These are microsatellites, consisting of a unit of two to 
thirteen nucleotides repeated hundreds of times in a row on the DNA strand, STR analysis measures 
the exact number of repeating units. A total of 23 STRs located on several chromosomes are analyzed as 
described in Methods. The results show no significant differences between sorted positive and negative 
cells in comparison to unsorted ones (Fig. S4 and S5).
Differential expression of miRNAs before and during overshoot. Human melanoma IgR39 cells 
express many miRNAs, as detailed in the supplementary data S1 (see Fig. S6). miRNAs influence most 
fundamental biological processes by ultimately altering the expression levels of proteins either through 
interference with mRNA translation or by reducing the stability of the mRNA in the cytoplasm20. Here, 
we consider how the miRNAs expression level evolves in time after sorting. As discussed in the Method 
section, we identify all the miRNAs that are significantly altered with respect to the unsorted condition 
for CXCR6- and CD271-marked cells after 3, 10 and 20 days. The results are reported in Fig. 3a in terms 
of their fold change with respect to the unsorted condition. First, note that the two subpopulations show 
the same trend, consistent with the fact that the CXCR6-positive subpopulation is also CD271-positive 
(Fig. S3). Second, note that more changes in miRNA expression appear at the overshoot at 10 days than 
at other times (Fig. 1). At 10 days, some miRNA levels increase in both marker populations (fold changes 
compared to the unsorted condition are reported in parentheses after miRNA names): miRNA 143—3p 
(5.6), miRNA 582—3p (4) and miRNA 582—5p (4). For the CXCR6-marked set only, we see an increase 
in miRNA 222—5p (2.4), while miRNA 181a-5p (4) increases only in the CD271-marked set. For both 
marker sets, most of the differential miRNA levels decrease (Fig.  3a). Before the overshoot, notable 
expression increases include miRNA 222—5p (6.5), with expression decreases for miRNAs 3607-5p, 3674 
and 4448 decrease (1/90, 1/111 and 1/10, respectively).
Based on the assumption that miRNAs function by targeting complementary mRNAs, we hypothesize 
that differential changes in miRNA levels will produce corresponding changes in targeted mRNAs, and 
Figure 3. Identification of differentially expressed miRNAs before and during the overshoot and the 
corresponding pathways involved. (a) The color map shows miRNAs that are are differentially expressed 
with respect to unsorted cells for CXCR6- or CD271- negative cells at 3, 10 and 20 days after sorting. The 
cells are also analysed immediately after sorting (0). We filter by p-value (< 10−5), fold change(> 2.0), and 
absolute expression (> 0.01%). Increased levels are reported in red, decreased levels in blue. (b) For each 
condition in panel a, we identify the significantly affected pathways using the Diana-MirPath database as 
described in Methods. The colormap shows the estimated p-value for each pathway at different times. The 
p-value represents the probability that a given pathway is significantly enriched with the presence of mRNA 
targets of each miRNA21.
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that mRNA targets can be predicted using bioinformatic tools that analyze miRNA-mRNA sequence 
complementarity. Using the Diana-MirPath database21, we match differentially expressed miRNAs with 
pathways described in the KEGG database. We find that Wnt and PI3K-AkT signaling pathways are the 
most targeted by the miRNAs, as assessed by the p-value estimated by Diana-MirPath that accounts for 
both the number of targeted genes and the number of overall genes in each pathway. Figure 2b displays 
the targeted pathways in terms of their statistical significance (p-value), while Fig. S7 reports the num-
ber of miRNAs targeting each pathway, and the number of targeted genes in each pathway. In Fig. 3a,c, 
we illustrate the network of interactions between the differentially expressed miRNAs before and at the 
overshoot in CXCR6-negative cells, respectively; Fig. 3b,d restrict these networks to highlight the Wnt 
and PI3K-Akt pathways identified in Fig.  3 as being especially significant. The interaction network is 
quite complex, displaying a remarkable degree of redundancy, with many miRNAs targeting the same 
pathway, and pleiotropy, with each miRNA targeting multiple genes and pathways. Interestingly, the 
level of miRNA 222—5p, which is identified as targeting the Wnt gene, increases significantly before the 
overshoot and then decreases at the overshoot.
Dynamic regulation of βcatenin before and during overshoot. In order to experimentally val-
idate the bioinformatic analysis suggesting that the Wnt signalling pathway is one of most significantly 
targeted by miRNAs before and at the overshoot, we investigate the dynamic regulation of βcatenin and 
other related factors such as Adenomatous Polyposis Coli (APC), Axin, and Glycogen Synthase Kinase 
3β (GSK3β). We restrict our analysis to the CXCR6-sorted population, because CXCR6-negative cells 
express the same miRNAs as CD271-negative ones (Fig. 3). In the absence of Wnt signals, βcatenin is 
found in two distinct multiprotein complexes: one complex, located at the plasma membrane, couples 
cadherins with the actin cytoskeleton, whereas the other complex containing the proteins APC, Axin, and 
GSK3β targets βcatenin for degradation. Wnt antagonizes the APC—-Axin—-GSK3β complex, resulting 
in an increase in the pool of free cytoplasmic βcatenin. Stabilized βcatenin translocates to the nucleus, 
binds LEF1/TCF4 factors and activates Wnt target genes, a process that may involve the disruption of 
Figure 4. Interaction network between miRNAs and pathways. (a) The network formed by differentially 
expressed miRNAs in CXCR6-negative cells before the overshoot (3 days after sorting) and pathways 
identified to be significantly targeted by those miRNAs. (b) The same network as in a) restricted to Wnt and 
PI3K signalling pathways. (c) The network formed by differentially expressed miRNAs in CXCR6-negative 
cells at the overshoot (10 days after sorting) and pathways identified to be significantly targeted by those 
miRNAs. (d) The same network as in (c) restricted to Wnt and PI3K signalling pathways. For all panels the 
miRNAs are shown in red when they increase and in blue when they decrease; the arrows are red when they 
induce an increase of the targeted pathway and in blue when they induce a decrease.
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interactions between LEF1/TCF4 and corepressor proteins. However, The LEF1/TCF4 transcription fac-
tors can also interact with other cofactors and play an architectural role in the assembly of multiprotein 
enhancer complexes, which may allow for the integration of multiple signalling pathways22. Using real 
time PCR, we quantify the level of expression of mRNA of βcatenin, Axin, APC, GSK3β, LEF1, TCF4 
as shown in Fig. 5a. After a significant decrease of all these factors 3 days after sorting, they all increase 
at the overshoot. Nevertheless, western blots show that βcatenin is not more activated at the overshoot 
(Fig. 5b). These results are in agreement with the intracellular localization of βcatenin detected by immu-
nofluorescence. In particular, βcatenin is localized at the cell membrane, 10 days after sorting, while it is 
more homogeneously distributed in unsorted cells (Fig. 5c). In addition, these cells express N-cadherin12 
whose expression also changes during switching (Fig. 5a). Finally, downstream factors also regulated by 
βcatenin, such as c—myc and cyclin D1 are also affected: before the overshoot cyclin D1 increases and 
N-cadherin decreases. At the overshoot, cyclin D1 decreases and N-cadherin increases.
Dynamic regulation of endothelial-mesenchimal transition factors before and during overshoot. 
We characterize CXCR6 phenotypic switching cells for the most important transcription factors playing 
a critical role in endothelial mesenchimal transition (EMT). This process promotes self-renewal capa-
bilities and the stem-like phenotype and is correlated to a poor prognosis of solid tumors23,24. Twist and 
Snail as well as Yap, which regulate the Hippo tumor suppressor pathway25, and Numb, a CSC marker 
for breast cancer26,27 all increase at the overshoot (Fig.  5a). Numb has been shown recently to play as 
a regulator of p53 preventing its ubiquitination and degradation26. Accordingly, during switching we 
observe an increase in the mRNA level of p53 (Fig.  5a). Under the same conditions, Sox9 and Oct4 
levels also increase (Fig.  5a). This appears to be in agreement with the role of Sox9 in adult stem cell 
maintenance28 and in melanoma29. In contrast, Nanog does not change and Sox2 decreases (4a). PTEN 
(phosphatase and tensin homologue) is another factor that plays a critical role in stem cell maintenance 
and its loss is involved in the development of CSCs30. As shown in Fig. 5a,d, PTEN first decreases when 
the level of the CSC markers is still low, and then increases at the overshoot. This is consistent with the 
role of PTEN for CSCs30: 3 days after sorting, when CSC are starting to switch, the level of PTEN is low, 
thus promoting CSC development. At the overshoot, when the population CSCs is large, PTEN is high 
leading to a subsequent reduction of the CSC population. Before the overshoot, the cells show a decrease 
of all EMT-related factors with the exception of Snail2 and p53 (Fig. 5a).
Figure 5. Expression of regulatory factors during phenotyping switching. (a) Colormap of real time PCR 
has been carried out on unsorted cells and CXCR6-negative cells 3 and 10 days after sorting as described 
in Methods. The colormap shows the log of fold change of each factor at different times after sorting. 
(b) Western blot of unsorted cells and CXCR6-negative cells 10 and 20 days after sorting as described in 
Methods. Tubulin has been used as housekeeping gene. (c) Immunofluorescence of βcatenin (green) and 
Falloidin (red) of unsorted cells (US) and CXCR6-negative cells 10 days after sorting (10 days).
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miRNA—222 silencing in CXCR6 negative cells during switching. To confirm the effect of 
miRNA—222 on the Wnt and PI3K-pathways, we silenced the unsorted and the marker-negative cells 
with Validated AMBION SILENCER Select siRNA 222. As control, siRNA targeted GAPDH has been 
used. As shown in Fig. S9, the silencing of miRNA222 in unsorted cells, leads to a specific change in 
a set of genes linked to Wnt and PI3K-pathways. To confirm the specificity of silencing, the silencing 
of the housekeeping gene GAPDH does not give the same pattern of siRNA222 but silences GAPDH 
only (Fig. S8). In sorted CXCR6 cells the silencing of miRNA—222 for 3 days affects the Wnt and PI3K 
pathways. In particular β-catenin is up-regulated as expected.
Population dynamics model miRNA-dependent is consistent with overshoot in phenotypic 
switching. To understand the observed CSC population dynamics in which the CSC-like cell pop-
ulation overshoots after sorting, we consider a simple mathematical model for the dynamics of hier-
archical cell populations with CSCs, cancer cells and senescent cells (Fig.  6a)16,31. In the absence of 
phenotypic switching, CSCs give rise to cancer cells and the reverse is not true31. Hence a perfectly sorted 
CSC-negative population does not express CSC markers again. If we introduce a small probability for 
cancer cells to switch back to the CSC state, CSCs will eventually reappear in the negative population but 
no overshoot would be observed6. We explain the presence of an overshoot assuming that the switch-
ing probability is usually zero but increases drastically after the activation of a miRNA network which 
responds to the lack of CSCs in the population. This mechanism is formalized in a mathematical model 
described in the supplement. We perform numerical simulations of the model, sorting and remixing 
CSCs and non-CSC cells as in Fig. 2. We then follow the dynamics of the CSC population, which displays 
an overshoot whose amplitude decreases as the initial fraction of CSCs increases (Fig. 6b).
CSCs in human breast cancer display related miRNA and transcriptome signatures. The 
identification of specific signatures for each tumor, and for tumor development to more aggressive con-
ditions, is a mainstream goal. Our data highlight the role of a set of genes regulating the transition 
between cancer cells to CSC in human melanoma. To assess whether these results might have implica-
tions for other cancers, we analyze the level of expression of the implicated set of genes in other kinds of 
human tumors such as breast cancer (METABRIC dataset; see Methods). First, we find that miRNA-222 
is more expressed in tumors that display the Embryonic Stem Cell (ESC) signature (fold change = 1.12, 
p-value = 0.002). Second, several important mRNAs that are modified in melanoma at the overshoot are 
seen to vary in ESC-like breast tumors (see Fig. 7a). Finally, we examined miRNAs that are significantly 
differentially expressed between ESC and non-ESC tumors, and we find that predicted mRNA targets of 
these miRNAs are involved in a set of relevant pathways, including Wnt and PI3K-AkT (Fig. 7b).
Discussion
The CSC hypothesis has been partially confirmed, despite the complex challenges of biomarker identi-
fication and the artificial environments presented by xenografts16. Three recent and independent papers 
Figure 6. Mathematical model explains CSC overshoot in phenotypic switching. (a) A schematic 
representation of the model considering CSC, cancer cells (CC) and senescent cells, with a possibility of 
phenotypic switching depending on the level of miRNA. (b) Simulations of the model for cell populations 
with different initial fraction of CSC display an overshoot in the fraction CSC for sufficiently low initial 
concentrations, in agreement with experiments.
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identified and validated the existence of a hierarchically organized aggressive subpopulation that sustains 
tumor growth in mouse models of brain5, skin4 and intestinal3 tumors: CSCs indeed exist and arise de 
novo during tumor formation in intact organs. However, the boundary between CSC cells and ordinary 
cancer cells appears more porous than originally conceived: several groups have shown that cancer cells 
can revert to the CSC state, although the biological mechanism leading to this phenotypic switching 
remained unclear6,11,32.
Here we provide clear evidence for an environmentally triggered, homeostatic population regulatory 
mechanism, controlled by epigenetic changes mediated by miRNA expression, governing the phenotypic 
switching in melanoma cell lines back to the CSC state. We do so using a multifaceted approach, com-
bining the use of CSC-specific markers and single-cell sorting to trigger switching, miRNA analysis of 
the concurrent inter-cell regulatory activity, and mathematical analysis of the resulting population shifts.
To segregate CSCs from the non-CSC population, we use three markers validated for human mela-
noma cells: CXCR6 (which also regulates the switch between asymmetric to symmetric cell division15), 
CD27110 and ABCG212. For all three markers, ten days after sorted negative cells are re-plated they 
display a significant overshoot in the re-expression of the marker. Furthermore, the amplitude of the 
overshoot is dependent on the percentage of positive cells present in the population, suggesting that 
the balance between positive and negative subpopulation is a factor in triggering phenotypic switching. 
When the number of positive cells in the population falls below a threshold, negative cells switch and 
become positive (CSC). This mechanism acts as an underdamped homeostatic mechanism, compensat-
ing for the depletion of CSCs and returning the population to the initial steady state. The fact that we 
find similar overshoots for the three markers is evidence both that the initial sorting is valid (keeping the 
same non-CSC subpopulation) and that the overshoot is multifaceted (reverting broadly to the original 
CSC phenotype). In addition, we show that CXCR6 positive and negative cells share the same STR pro-
files, suggesting that they do not differ genetically. The overshoot and the lack of significant mutations 
indicates that the switching is not a statistically random event, but is regulated by the CSC population.
To explore the regulatory mechanism, to show that it involves the tumor population as a whole (and 
not a hyperstimulated mis-sorted CSC population), and to definitively show that the CSC switching is 
due to intrinsic factors released by the cells rather than extrinsic factors, we study the miRNA expression. 
We focus on miRNAs as a possible way used by cells to communicate between each other and to produce 
the factors needed to switch. miRNAs are epigenetic factors that control crucial aspects of cellular life 
such as duplication, differentiation and stem-cell-like phenotypes. It is known that even small differences 
in miRNA expression levels can have profound functional consequences for fundamental cellular pro-
grams33. Since we are not aiming to validate a specific miRNA for melanoma, we use a well-characterized 
typical human melanoma cell line, which importantly expresses high levels of CSC markers and origi-
nates from a primary tumor15,17,31. Evidence of phenotypic switching in different melanoma cell lines has 
Figure 7. mRNA and miRNA expression in breast tumors with ESC signature. mRNA expression data 
from 1980 breast tumors and miRNA expression data from 1283 breast tumors47,55 are separated in two 
classes depending on the presence of an ESC signature56. (a) We report a set, corresponding to the factors 
in Fig. 5a, of significantly changed mRNA between ESC and non-ESC tumors. The color represents the 
relative fold-change of each mRNA for the two sets of tumors. (b) A large set of miRNA are significantly 
over-expressed (OE) or under-expressed (UE) between ESC and non-ESC tumors. We report the pathways 
putatively targeted by these two sets of miRNAs. The color represent the p-value. A low p-value suggests that 
the pathway is likely to be targeted by the set of OE or UE miRNAs.
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been reported by our group and others (WM11512 and WM37347). The basal miRNA expression in cell 
line used here is high, suggesting an intense regulatory activity and strong interactions between cells.
Before and after the overshoot, we identify all the miRNAs that are differentially expressed compared 
to the unsorted condition. The results are largely independent of the marker used for sorting, consist-
ent with the co-expression of CXCR6 with the other markers. Based on a bioinformatic analysis, we 
observe that miRNAs act in a pleiotropic and redundant manner affecting many intracellular pathways 
and therefore creating an intricate network of connections. In spite of the complexity of the network, 
two main pathways appear to be primarily targeted by the differentially expressed miRNAs: the Wnt and 
PI3K signalling pathways. Before the overshoot, miRNA 222—5p (targeting Wnt), increases, contribut-
ing to a decrease of the activity in the Wnt-pathway and in the level of βcatenin. The βcatenin level in 
the plasma membrane is indeed clearly shifted at the overshoot. This is consistent with the observation 
of an interesting recent paper on embryonic stem cells, where the transcriptional activity of βcatenin 
under self-renewal conditions was shown to be negligible due to its membrane localization and the sub-
sequent complex formation with Oct434. We also compared the behavior of CXCR6 negative cells with 
that of unsorted cells to silencing of miRNA—222. In both cases silencing led to the expected increase 
in βcatenin. But the unsorted cells also showed an increase of LEF1, TCF4, Axin, Twist, Snails and p53, 
an increase not observed in CXCR6-negative cells. Thus the response of negative and unsorted cells to 
silencing this stimulated pathway also differs.
The main function of PTEN is to negatively regulate the PI3K-Akt pathway. The loss of PTEN results 
in an overactive Akt, which induces proliferation and promotes survival by inhibiting apoptosis35. 
Accordingly, in hematopoietic stem cells cooperation between PTEN and Wnt pathways occurs during 
phenotypic switching36. Recently, PTEN-null melanocyte stem cells have been shown to be resistant to 
exhaustion after repeated depletions, a phenotype that is similar to the one observed in PTEN-null neural 
stem cells37. Interestingly, PTEN is regulated during phenotypic switching and increases substantially, 
together with p53, when the cells are re-expressing the CSC phenotype. It is well known that PTEN can 
regulate p53 protein levels and its transcriptional activity38. A dynamic regulation of Wnt and PTEN-p53 
pathways occurs and regulates the phenotype of negative cells due to the differentially expressed miR-
NAs: before the overshoot, when negative cells are about to switch, PTEN and βcatenin are low, while at 
the overshoot PTEN and p53 increase, contributing to differentiation and thus decreasing the number 
of CSCs to their steady state level. This is in line with a recent review discussing the role of p53 as the 
barrier to CSC formation: p53 is necessary to maintain a pool of normal stem cells by controlling their 
quantity and quality39. These properties are still present in CSCs.
Another intriguing aspect of our experimental results is the relation between CSC switching and the 
epithelial—mesenchymal transition (EMT), a profound event for large-scale cell movement during mor-
phogenesis at the time of embryonic development. During this process, epithelial cells lose contact with 
their neighbors and gain mesenchymal properties, enabling them to break through the basement mem-
brane that separates different tissues within the embryo40. Because a similar process has been observed 
at the invasive front of metastatic cancer, the EMT is considered to be a hallmark of neoplastic transfor-
mation. The EMT results from the induction of transcription factors that alter gene expression to pro-
mote loss of cell—cell adhesion, leading to a shift in cytoskeletal dynamics and a change from epithelial 
morphology and physiology to the mesenchymal phenotype. Before the overshoot, all the EMT factors 
decrease with the exception of Snail2. Emerging evidence indicates that Snail confers to CSC-like traits to 
tumor cells, promoting drug resistance, tumor recurrence and metastasis41. Moreover, direct regulation 
of the Snail promoter is due to different growth factors, such as TGF—β42. The latter is one of the path-
ways targeted by miRNAs before the overshoot. On the other hand, the expression of Snail appears to 
be closely related to metastasis41, in accordance with the increased level of CSCs at the overshoot. Twist, 
also involved in the EMT, is also increased at the overshoot43. However, at the overshoot (when the cells 
are expressing PTEN and p53) the levels of cyclin D1 and c—myc decrease whereas SOX9 (shown to be 
expressed in more differentiated melanoma phenotypes) increases29.
In order to understand how an overshoot in the expression of CSC markers can possibly arise after 
sorting, we turn to a mathematical model for the population dynamics of cancer cells. Previous models 
for phenotypic switching introduce a small probability for cancer cells to switch back to the CSC state6,16. 
Such models predict that the CSC population will re-approach its steady-state concentration after sort-
ing, but without an overshoot. In our model, the switch probability is dependent on the expression level 
of a set of relevant miRNAs which is in turn controlled by the population of CSCs. When the CSC 
population is depleted, the miRNA expression level shoots up, triggering a large switching probability. 
This induces an overshoot in the fraction of CSCs in the population that then falls back to the steady 
state level as the level of miRNAs decreases. The model illustrates in simple terms how cancer cells react 
to the depletion of CSCs, showing that phenotypic switching is not just a random event, as assumed in 
previous works6, but an active response to a depletion of the CSC population.
A similar protective mechanism might be at play in stem cells niches: without switching, our model is 
very similar to a stochastic model for stem cell evolution that has been found to describe accurately the 
distribution of clone size in vivo44. In the case of stem cells, however, tissue homeostasis requires that, on 
average, each stem cell gives rise to one stem cell (i.e., the parameter ε is equal to zero31). In these condi-
tions, the model predicts that the probability of extinction for a clone originating from a single stem-cell 
tends to one in the long-time limit45 but when the stem cell pool is large enough, fluctuation-induced 
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extinction is very unlikely44. If an external perturbation suddenly reduces the stem cell pool, however, 
the model predicts that extinction becomes likely. Phenotypic switching represents an effective response 
to this threat.
More broadly, (non-cancerous) stem cells are thought to be subject to two homeostatic regulatory 
mechanisms46. As above, the first keeps the stem cell population near a fixed number. We model this 
first homeostasis mechanism in CSCs not by regulating the probability of symmetric divisions into CSCs, 
but by introducing a regulated switch into the CSC state. This choice is suggested by the concentration 
dependence of the overshoot; a more complete depletion of CSCs would take longer to recover in a 
model of regulated CSC symmetric divisions, but would respond more quickly in a switching model — 
as observed in our experiments (Fig. 2c). The second homeostatic mechanism in stem cells is thought 
to regulate the generation of new differentiated cells to control their number (e.g., organ size). Perhaps 
the cancer cell lines we study have lost the second control mechanism, but retain the first? All together, 
our data show that the number of CSCs is controlled by a complex network of miRNAs that regulate in 
particular the Wnt and PTEN pathways and EMT-related factors. We show that a similar set of genes is 
expressed in METABRIC ESC-like human breast tumors47 with respect to non ESC, demonstrating that 
this signature is not specific to melanoma. Interestingly, in the same dataset miRNA—222 is significantly 
increased.
A direct consequence of our findings is that reducing the number of CSCs below a threshold induces 
the cells to switch. Rather than targeting and decreasing the CSCs as the ‘root’ of the cancer, our findings 
suggest that a balanced reduction in both populations is needed to keep the tumor in a state of asymmet-
ric cell division as it is reduced. In stem cells the locality of Wnt signalling dictates differentiation and 
spatial confinement in a niche48. Our results suggest that CSCs and their offspring exhibit the presumed 
stem cell capability of regulating the number of stem cells in the niche and thus avoid extinction. We 
are not, however, aware of a switching mechanism from differentiated cells to stem cells being used to 
achieve this end in stem cell niches. A practical consequence of these findings is that since IgR39 cells 
are heterozygous for the BRAF V600 mutation (Fig. S9), a drug acting on such a factor should affect both 
CSCs and cancer cells. It could thus shrink the tumor at short times but lead to a relapse of the tumor at 
longer times due to the depletion of CSCs, inducing a switch in the population. This is in agreement with 
a recent paper where a minor subset of melanoma cells, required for tumor maintenance and expressing 
high levels of Jarid1B, are shown to undergo a marked expansion when treated with either BRAF inhib-
itors or cytotoxic chemotherapeutic drugs7. At least for melanoma, the best strategy seems to be to find 
a balance for the percentage of CSCs so that it does not fall below threshold, or a complete resection of 
the tumor. In addition, miRNA-222 is a promising target for suppressing phenotypic-switching replen-
ishment in CSC-depleted tumors, not only in melanoma but also in breast cancer.
Methods
Cell lines. Human IGR39 cells are obtained from Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH and cultured as previously described (standard conditions)15.
Flow Cytometry. Cells are analyzed or sorted for phycoerythrin (PE) anti-human CXCR6 (R& D 
System, Minneapolis, MN), PE anti human CD271 (BD Pharmingen), fluoroscein isothiocyanate (FITC) 
anti-human ABCG2 (R& D Systems, Minneapolis, MN), FITC anti human fascin (Abcam, ab126772). 
Indirect flow cytometry is carried out with anti human p53 (Abcam Ab156030), anti human MKAC 
(Abcam, Ab187652) or anti human PTEN (Abcam, Ab32199). Secondary FITC antibody is used for 
indirect florescent (1:250, Alexa Fluo 488). All samples are analyzed using one flow cytometry with 
non-specific mouse IgG used as isotype controls. For each flow cytometry evaluation, a minimum of 
5 × 105 cells were stained and at least 50000 events were collected and analyzed (106 cells were stained for 
sorting). Flow cytometry sorting and analysis was performed using a FACSAria flow cytometer (Becton, 
Dickinson and Company, BD, Mountain View, CA). Data were analyzed using FlowJo software (Tree 
Star, Inc., San Carlos, CA). For double staining with CXCR6 and CD271 markers, the cells are incu-
bated with FITC anti-human CXCR6 (R& D System, Minneapolis, MN) and PE anti human CD271 
(BD Pharmingen).
Short tandem repeat (STR) analysis. DNA is extracted by DNA MiniPrep kit (GN170, Sigma) and 
amplified using the commercial kits NGMSelect (Applied Biosystems)49 and Powerplex 1650 (Promega) 
following the manufacturers’ instructions. The amplified loci are: D10S1248, VWA, D16S539, D2S1338, 
D8S1179, D21S11, D18S51, D22S1045, D19S433, TH01, FGA, D2S441, D3S1358, D1S1656, D12S391, 
SE33+ Amelogenin (NGMSelect) and D3S1358, TH01, D21S11, D18S51, PENTA E, D5S818, D13S317, 
D7S820, D16S539, CSF1PO, PENTA D, VWA, D8S1179, TPOX, FGA+ Amelogenin (Powerplex 16). 
The chromosomal location of the analysed STRs is displayed in Tables S1 and S2 and Figs S4 and S5. 
The resolution of the amplified fragments was carried out on ABI 310 Genetic Analyzer, followed by 
Genescan 3.1.2 and Genotyper 2.1 or GeneMapper 3.2 analysis. All the procedure of STR typing was 
repeated at least twice for each sample.
BRAF V600 mutation. Using standard PCR conditions, BRAF exon 15 was amplified using the pro-
tocol of Davies et al.51.
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Immunofluorescence. Subconfluent cells grown on glass coverslips are fixed with 3.7% parafol-
maldeide in PBS for 10min, permealized with 0.5% Triton X-100 in PBS for 5min at room temperature 
and incubated with 10% goat serum in PBS for 1hr. The cells are stained with polyclonal anti-CXCR6 
antibody (1:400, Abcam, Ab8023) or anti-β-catenin (MIllipore, MAB2081, 1:200 nostro; anti-Active 
βCatenin (Anti-ABC) Antibody, Millipore, 05-665, 1:50) or Anti-Fascin antibody (DyLight 488, ab156578 
Abcam) overnight at 4 °C. Thus, after a brief washing with PBS, CXCR6 staining cells are incubated with 
the secondary antibody (anti rabbit Alexa488 1:250) for 1 h. The cytoskeleton is stained with Falloidin 
(Acti-stain 555 Fluorescent Phalloidin, Cytoskeleton Inc, 100 nM) at room temperature for 45 min. The 
nuclei are counterstained with DAPI and the slides mounted with Pro-long anti fade reagent (Life tech-
nologies). The images are acquired with a Leika TCS NT confocal microscope.
Isolation and detection of miRNAs. miRNeasy Micro kit (Qiagen, 217084) has been used for the 
purification of total RNA including miRNA according to the manufacturer’s instructions. The integrity 
of total RNA samples is checked by Agilent Technologies Bioanalyzer 2100 through calculation of the 
RNA Integrity Number (RIN). Samples with RIN greater or equal to 8 are used for library preparation 
of total RNAs. The Illumina TruSeq Small RNA Sample Preparation kit is used to prepare libraries of 
miRNA suitable for sequencing. The sample preparation is performed using 1μg of input total RNA. 
The first step of the sample preparation consisted in ligating sequences (“adapters”) to the miRNAs. 
The protocol takes advantage of the natural structure common to most known miRNA molecules. Most 
mature miRNAs have a 5′ -phosphate and a 3′ -hydroxyl group as a result of the cellular pathway used 
to create them. The Illumina adapters in this kit are directly, and specifically, ligated to miRNAs. After 
adapter ligation, reverse transcription followed by PCR was used to create cDNA constructs based on 
the small RNA ligated with 3′ and 5′ adapters. This process selectively enriches those fragments that 
have adapter molecules on both ends. PCR is performed with two primers that anneal to the ends of the 
adapters. In one of two primers a sequence “tag” is present (index sequence). Each sample is added with 
a unique index sequence. The amplified libraries are checked on Bioanalyzer 2100 to verify the presence 
of the peaks corresponding to the miRNAs (peaks range from 145 bp to 158 bp). In Fig. S6 we show an 
example of the electropherogram of one of the amplified libraries. The checked amplified libraries are run 
on 6% Novex TBE Gel and the 147 nt band containing mature miRNA and the 157 nt band containing 
piwi-interacting RNAs, as well as some miRNAs and other regulatory small RNA molecules, are selected 
from the gel, purified and checked on Bioanalyzer chip. In Supplementary Fig. 2 a final library ready to 
be sequenced is reported. The 12 libraries are pooled together and the pool is sequenced on Illumina 
platform. Sequencing of the pool is performed on Illumina HiSeq1500 platform in single read protocol 
with the production of sequences of 50 bp in length. The number of reads produced per sample ranges 
from 6.8 million and 12.3 million. The percentage of ≥ Q30 Bases (PF) and Mean Quality Score (PF) are 
two parameters used to estimate the quality of the sequencing run and of the produced sequences. Both 
the percentage of Q30 Bases (PF) and Mean Quality Score (PF) are higher (> 98.16 and > 38, respec-
tively), suggesting a run of good quality.
miRNAs analysis. The FASTQ sequences were trimmed to remove the adapter sequences using the 
Cutadapt software toolbox52. The correctness of trimming and the initial sequence quality assessment was 
made using the combined software toolboxes TrimGalore! (http://www.bioinformatics.babraham.ac.uk/
projects/trim galore/) and FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Data 
indicate high signal to noise ratio; no spurious sequences are detected in any of the samples. We counted 
the unique trimmed sequences and, for each sample, generated files listing all the unique sequences 
with the corresponding number of occurrences. The sequence occurrence files were uploaded to the 
Miranalyzer online tool53 as input data; Miranalizer was run, using the default parameters, singularly 
on all 12 data sets to identify predicted miRNA sequences. We compared the unsorted conditions (US) 
with all the other conditions selecting candidate miRNAs by filtering according to p-value (< 10−5), fold 
change(> 2.0), and absolute expression(> 0.01%). This allows us to concentrate on good candidates (low 
p-value) that have undergone a significant change in expression and presumably do not represent false 
positives due to very low concentration.
Identification of target pathways. We consider the set of miRNAs corresponding to each exper-
imental condition as in Fig. 3) and use the online database Diana-MirPath21 to identify targeted genes 
and pathways.
Real Time PCR. Total RNA has been isolated by NucleoSpin RNA II Kit (Macherey-Nagel, Germany). 
1μg is reverse transcribed with random hexamers (High Capacity cDNA Archive Kit; Applied Biosystems) 
in accordance with the manufacturer’s instructions. cDNA(5 ng) is amplified in triplicate in a reaction 
volume of 15μl with the TaqMan Gene Expression Assay (Applied Biosystems) and anABI/Prism 7900 
HT thermocycler, using a pre-PCR step of 10 minutes at 95 °C, followed by 40 cycles of 15 seconds at 
60 °C. and 60 seconds at 60 °C. For any sample the expression level, normalized to the housekeeping 
gene encoding GAPDH, is determined with the comparative threshold cycle (Ct) method as previously 
described54. Primers used for Real Time PCR are reported by Spagnuolo54 and in Table S3.
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Western Blot. Confluent cells were lysed by boiling in a modified Laemmli sample buffer (2% SDS, 
20% glycerol, and 125 mM Tris-HCl, pH6.8). Equal amount of proteins were loaded on gel and sepa-
rated by SDS-PAGE and transferred to a Protran nitrocellulose membrane (Whatman). After blocking, 
primary and HRP-linked secondary antibodies, specific bindings were detected by chemiluminescence 
system (GE Healthcare).
Population dynamics model for miRNA induced phenotypic switching. We propose a simple 
model for CSC population dynamics including CSCs S, duplicating cancer cells C and non duplicating 
(senescent) cells D. The kinetics for the model is based on the fact a CSC duplicates symmetrically into 
two CSC with probability p2 or into two cancer cells with probability p0, or asymmetrically into one CSC 
and one cancer cell with probability p1, such that + + =p p p 10 1 2 . The kinetics of the model only 
depends on the combination ε = −p p2 0, the average relative increase in the number of CSCs after one 
duplication31 Cancer cells can switch to CSCs with a probability p(μ) depending on the concentration of 
relevant miRNAs μ, or duplicate and give rise to two non-duplicating cancer cells with probability 1 − p. 
For simplicity the rates of duplication and switching are taken to be equal to Rd for all the cells 
yielding:
ε µ= ( + ( )( + )), ( )
dS
dt
R S p C D 1d
ε µ= ( − ) − ( + ( )), ( )
dC
dt
R S C p1 1 2d
µ= ( − ( ) ). ( )
dD
dt
R C p D2 3d
When p = 0 the model is equivalent to the CSC model introduced in LaPorta et al.31 (in the limit M = 1), 
while the case of constant p has been studied in16. Here we study the case in which the switching prob-
ability is not constant but is controlled by the level of relevant miRNAs, which responds to the depletion 
of the CSC population, as observed experimentally. We assume that the miRNAs regulating phenotypic 
switching are produced with a rate that rapidly vanishes when the fraction of CSCs = /( + + )f S S C DS  
is sufficiently large, and are cleared at constant rate γ:
( )µ β γµ= − / − . ( )
d
dt
f sexp 4s 0
The switching probability is activated when the level of miRNA is above a threshold μ0. To avoid artificial 
singularities, we model the threshold by a smooth sigmoid function
µ µ µ σ( ) = ( + (( − )/ )). ( )p 1 tanh 50
Simulations are performed using a custom made python code. Parameters (Rd = 0.4 days−1, ε = .0 05, 
µ = .10 , σ = .0 03, = .s 0 0050 , β = 1 days
−1, γ = .0 015 days−1) are chosen in a way that yields a dynam-
ics similar to the experiments.
miRNA-222 silencing protocol. miRNA-222 is silenced by reverse transfection according to 
the manufacturer’s instructions using Validated AMBION SILENCER Select siRNA 222 (4390818, 
LifeTechnology). As positive control siRNA targeted GAPDH is also used (4390849, AMBION, Life 
Technology). Lipofectamine RNAiMAX transfection reagent is used to transfect the cells according to 
Invitrogen protocol. The cells are collected 72 hrs after transfection for further studies.
Analysis of miRNA and transcriptome of human breast cancer. We used the METABRIC data-
set of human breast tumor that contains mRNA expression data of 1980 tumors and 1283 miRNA expres-
sion47,55. We also used the ESC-like signature which identified a set of genes from 13 genes sets associated 
with human ESC identity56. We divided the METABRIC patients into ESC-like and non ESC-like tumors. 
In particular, as described by Ben Porath et al.56, tumors with overexpression of the ESC exp1 gene 
set and underexpression of the PRC2 targets genes set were defined as ES-like tumors (418 tumors), 
while tumors with underexpression of the ESC exp1 set and overexpression of the PRC2 targets set 
were defined as non ESC-like tumors (666 tumors). 7122 genes were significantly overexpressed in the 
METABRIC ESC-like tumors, and 5594 genes were significantly underexpressed (1% FDR; 2-samples 
t-test). Among the METABRIC tumors which were divided into ESC-like and non ESC-like tumors, 
miRNA expression data was measured on 255 ESC-like and 457 non ESC-like tumors. 156 miRNAs were 
significantly overexpressed in the ESC-like tumors, and 163 miRNAs were significantly underexpressed 
(1% false discovery rate; 2-samples t-test).
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Statistical Analysis. Statistical significance analysis is performed using the Kolmogorov-Smirnov 
test.
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